Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 30;24(3):102-109.
doi: 10.1136/ebmental-2020-300223. Online ahead of print.

Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study

Affiliations

Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study

Peter Irving et al. Evid Based Ment Health. .

Abstract

Background: Inflammatory bowel disease (IBD) has a significant impact on quality of life for many people.

Objective: To assess the prevalence of common mental health conditions in IBD and the combined impact of IBD and mental health conditions on healthcare use and time off work.

Methods: A UK population-based primary care database (Royal College of General Practitioners Research and Surveillance Centre) was used to identify adults with IBD (n=19 011) (Crohn's disease (CD) or ulcerative colitis (UC)), and matched controls (n=76 044). Prevalences of anxiety, depressive episodes and depressive disorder recorded in primary care were assessed between 2016 and 2018. Outcomes comprised of rates of primary care visits, emergency secondary care visits, certificates for time off work, antidepressant and anxiolytic prescriptions.

Findings: Mental health conditions were more common in people with CD than controls: anxiety episodes (3.5% vs 3.0%; p=0.02), depressive episodes (5.7% vs 4.1%; p<0.001) and depressive disorder (17.5% vs 12.9%; p<0.001), and people with UC versus controls: depressive episodes (4.4% vs 3.6%; p<0.001) and depressive disorder (14.2% vs 12.4%; p<0.001). Healthcare utilisation rates were higher in people with IBD than controls (primary care visits incidence rate ratio 1.47 (95% CI 1.43 to 1.51); emergency secondary care visits 1.87 (1.79 to 1.95); fitness for work certificates 1.53 (1.44 to 1.62); antidepressant use 1.22 (1.13 to 1.32); anxiolytic use 1.20 (1.01 to 1.41)). In people with IBD, mental health conditions were associated with additional increases in healthcare use and time off work.

Conclusion: Depression and anxiety are more common in people with IBD than matched controls. Healthcare utilisation and prescribing of psychotropic medications are also higher in people with IBD. Mental health conditions in people with IBD are associated with additional healthcare use and time off work.

Clinical implications: Evidence-based mental health support programmes, including psychological treatments, are needed for people with IBD.

Keywords: adult psychiatry; anxiety disorders; depression & mood disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests: KB has received honoraria from Tillots, Thermo Fisher Scientific, Boehringer Ingelheim, Pfizer and Yakult. PI has received lecture fees from AbbVie, Celgene, Falk Pharma, Ferring, MSD, Janssen, Pfizer, Takeda, Tillotts, Sapphire Medical, Sandoz, Shire and Warner Chilcott; financial support for research from MSD, Pfizer and Takeda; advisory fees from AbbVie, Arena, Genentech, Gilead, Hospira, Janssen, Lilly, MSD, Pfizer, Pharmacosmos, Prometheus, Roche, Sandoz, Samsung Bioepis, Takeda, Topivert, VH2, Vifor Pharma and Warner Chilcott. MN is an employee of Pfizer. SdL is director of the RCGP RSC, he has received funding from Eli Lilly, GSK, Astra Zeneca, MSD, Sanofi, Seqirus and Takeda, all through his universities and none related to this study.

Figures

Figure 1
Figure 1
Healthcare resource use in people with IBD and matched controls during 3 years of follow-up. Data are rates per person-year, with 95% CIs. The absolute rates are provided in online supplemental table 9. CD, Crohn’s disease; IBD, inflammatory bowel disease; UC, ulcerative colitis; SSRIs, selective serotonin reuptake inhibitors.
Figure 2
Figure 2
Association of common mental health conditions with rates of (A) primary care visits, (B) emergency secondary care visits and (C) fitness for work notes, in people with IBD. Estimates are adjusted incidence rate ratios (IRRs) with 95% CIs. For each mental health condition, IRRs represent the relative change in rate of the healthcare utilisation measure if the condition is present compared with if the condition is absent. An IRR greater than 1 indicates that the presence of a mental health condition is associated with an increased rate of healthcare utilisation. All estimates are adjusted for age at study entry, sex, duration of IBD, current use of systemic therapy, BMI and Index of Multiple Deprivation quintile (for full models see online supplemental table 11). Fitness for work notes are included as indicators of absenteeism from work due to ill health. BMI, body mass index; IBD, inflammatory bowel disease.

References

    1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet 2007;369:1641–57. 10.1016/S0140-6736(07)60751-X - DOI - PubMed
    1. Romberg-Camps MJL, Bol Y, Dagnelie PC, et al. . Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137–47. 10.1002/ibd.21285 - DOI - PubMed
    1. Jones JL, Nguyen GC, Benchimol EI, et al. . The impact of inflammatory bowel disease in Canada 2018: quality of life. J Can Assoc Gastroenterol 2019;2:S42–8. 10.1093/jcag/gwy048 - DOI - PMC - PubMed
    1. Kawalec P. Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review. Arch Med Sci 2016;12:295–302. 10.5114/aoms.2016.59254 - DOI - PMC - PubMed
    1. Gracie DJ, Hamlin JP, Ford AC. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. Am J Gastroenterol 2018;113:702–12. 10.1038/s41395-018-0021-z - DOI - PubMed